A 2026 systematic review of oral doxycycline for acne vulgaris mainly studied adolescents and young adults with moderate-to-severe inflammatory facial acne. It did not provide a separate result for adults with persistent acne, while pregnant patients and children through age 8 are not doxycycline candidates.
Doxycycline is an oral antibiotic that reduces acne bacteria and skin inflammation. The U.S. National Library of Medicine lists the review as pooling 23 randomized trials with 2,672 patients using PRISMA methods the PubMed record.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who was actually studied?
- What did the review measure?
- How did doxycycline compare?
- Who was not included and what should adults do?
Who was actually studied?
The trials focused on moderate-to-severe inflammatory facial acne. Patients were largely teenagers and young adults with papules, pustules, and comedones. One adult example defined moderate acne as 6-200 comedones plus 10-75 papules.
That 51-adult trial was summarized by MDedge Family Medicine the Skidmore trial summary. It shows the type of inflammatory acne included. Adults with persistent acne beyond the teen years were not analyzed as a distinct group. Readers over 25 with ongoing jawline, chin, or hormonal-pattern breakouts should not assume the average result fits them exactly.
What did the review measure?
The review tracked treatment success, change in inflammatory lesion count, and Global Acne Grading System scores. The National Institutes of Health repository reports safety as reported adverse events the full review text. Treatment success means clear or almost-clear skin by trial criteria. Lesion-count change measures fewer red, tender bumps.
GAGS combines lesion type, number, and location into one severity score. These outcomes matter for different decisions. Success and lesion counts reflect visible improvement. GAGS and adverse events help compare overall benefit against side effects.
How did doxycycline compare?
Doxycycline performed much like azithromycin for clearing acne. The NIH repository reports similar treatment success and a small, nonsignificant lesion-count difference the full review text. The same review found stronger GAGS improvement with control treatments than with doxycycline.
That result limits any claim that doxycycline is superior across every measure. Tolerability differed as well. Dermatology Times notes gastrointestinal events and photosensitivity with doxycycline, with fewer gastrointestinal symptoms reported for azithromycin pulse therapy the February 2026 comparison. Sun protection and food timing often matter during doxycycline courses.
Who was not included and what should adults do?
Pregnant patients and children through age 8 were not eligible populations. The U.S. FDA label states tetracyclines including doxycycline can cause permanent yellow-gray-brown tooth discoloration during tooth development the DailyMed label.
The 2024 American Academy of Dermatology guideline strongly recommends oral doxycycline for acne. It reserves oral isotretinoin for severe, scarring, psychosocially burdensome, or treatment-resistant acne the Academy guideline summary. Adults with persistent acne can use the review as a starting point, not a personal prescription. Ask a dermatologist about these points: Bring your acne history, past antibiotics, sun sensitivity, and pregnancy plans to that visit.
- acne location, severity, scarring, and prior antibiotic response
- pregnancy status, breastfeeding, or planned pregnancy
- stomach sensitivity, sun exposure, and other medicines
- whether topical retinoids, benzoyl peroxide, hormonal care, or isotretinoin fit severe or resistant disease
You Might Also Like
- The 2026 Review of Topical Antibiotic Monotherapy for Acne: Who Was Studied and Who Was Not for Adults With Persistent Acne
- The 2026 Network Meta-Analysis of Topical Acne Antibiotics: Who Was Studied and Who Was Not for Adults With Persistent Acne
- Spironolactone, Metformin, and Bicalutamide for Acne in a 2026 Review: Who Was Studied and Who Was Not for Adults With Persistent Acne